Ajanta Pharma Ltd. (AJANTPHARM): Ajanta Pharma Share Price rises 2.74% to Rs 3,597.20
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Ajanta Pharma Share Price rose today as the stock moved to Rs 3,597.20, up 2.74% from the previous close of Rs 3,501.35. The company’s market capitalisation stood at Rs 43,743.16 crore, placing the move in the context of a sizeable listed healthcare name. The day’s range stretched from Rs 3,524 to Rs 3,634.85, while turnover was Rs 0.28 crore.
This Ajanta Pharma Share Price update confirms a clear same-day price rise, but the supplied data does not establish a company-specific catalyst. For readers tracking Ajanta Pharma Share Price Today, the useful question is not only what changed in the stock, but how the valuation, profitability and sector context line up with the move. That is where Univest can help frame the AJANTPHARM story in a structured way. The stock also remains relevant for searches such as Ajanta Pharma Stock News and Ajanta Pharma Share Price News because the market is reviewing the latest price action alongside financial ratios and industry comparisons.
Ajanta Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,597.2 |
| Previous Close | Rs 3,501.35 |
| Today's Move | Rs 95.85 (+2.74%) |
| Open | Rs 3,524 |
| High | Rs 3,634.85 |
| Low | Rs 3,524 |
| Turnover | Rs 0.28 crore |
| Market Capitalisation | Rs 43,743.16 crore |
| Market Cap Category | Large Cap |
Ajanta Pharma Ltd. (AJANTPHARM) rose to Rs 3,597.2 from the previous close of Rs 3,501.35, a move of Rs 95.85 or 2.74%. The stock opened at Rs 3,524, reached a high of Rs 3,634.85, recorded a low of Rs 3,524.
Ajanta Pharma Share Price today opened at Rs 3,524, matched the day low at Rs 3,524, and touched Rs 3,634.85 before settling at Rs 3,597.20. That left the stock Rs 95.85 higher than the previous close, reflecting a 2.74% daily gain. The move kept Ajanta Pharma Share Price within the broader day range and away from the session low by a meaningful margin. Turnover of Rs 0.28 crore provides a factual traded-value reference for the session. For investors scanning Ajanta Pharma Stock Gaining Today and Ajanta Pharma Share Price Live, the numbers show a firm up day, while the supplied data stops short of identifying a catalyst. Univest presents this as a verified price rise rather than a story built on speculation.
Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 43,743.16 crore |
| P/E Ratio | 38.55x |
| P/B Ratio | 9.01x |
| ROE | 25.42% |
| ROCE | 32.67% |
| EPS | Rs 90.82 |
| Book Value Per Share | Rs 388.77 |
| Dividend Yield | 0.8% |
Ajanta Pharma Ltd. (AJANTPHARM) fundamental metrics show P/E 38.55x, P/B 9.01x, ROE 25.42%, ROCE 32.67%. These figures provide context only and are not a buy or sell signal.
Ajanta Pharma Ltd. has a market capitalisation of Rs 43743.16 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.55x, P/B at 9.01x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.42% and ROCE of 32.67%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 90.82, book value per share of Rs 388.77, dividend yield of 0.8%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.55x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 9.01x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 25.42% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 32.67% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 43,743.16 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 38.55x, which is above the benchmark median of 32.69x, a difference of +17.93%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of 25.42%, which is above the benchmark median of 11.78%, a difference of +115.79%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of 32.67%, which is above the benchmark median of 13.65%, a difference of +139.34%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 38.55x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.42% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 32.67% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 43,743.16 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Ajanta Pharma
- Ajanta Pharma Share Price rose 2.74% today to Rs 3,597.20.
- The stock added Rs 95.85 over the previous close of Rs 3,501.35.
- Market capitalisation stood at Rs 43,743.16 crore.
- P/E of 38.55 and P/B of 9.01 place Ajanta Pharma above the industry median on valuation.
- ROE of 25.42% and ROCE of 32.67% are both above the same-industry median and average.
About Ajanta Pharma
Ajanta Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s market cap, valuation ratios and return metrics show that it is a well-followed listed pharma business in the Indian Stock Market. On the supplied numbers, Ajanta Pharma Share Price reflects a company with a premium P/E, a premium P/B and strong profitability ratios relative to the benchmark set.
For investors reading Ajanta Pharma Stock Performance alongside Ajanta Pharma Latest News, the relevant business story is a listed pharmaceutical company whose financial profile is defined more by returns on capital and equity than by a simple one-line narrative. The current data set does not provide revenue split, segment mix or geographic detail, so the visible analysis remains focused on the verified market and financial figures. Univest keeps that distinction clear and avoids adding unsupported business claims.
Track Ajanta Pharma Share Price on Univest
Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Ajanta Pharma Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. The same page also helps compare Ajanta Pharma Share Price Today with sector peers, valuation context and company news in one place. Univest brings the latest stock context together without adding assumptions or prediction.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Ajanta Pharma Share Price rise today?
Ans. Ajanta Pharma Share Price rose 2.74% to Rs 3,597.20, but the supplied data does not establish a company-specific catalyst. The verified record confirms the price event and turnover, not the reason behind it.
What was Ajanta Pharma Share Price today’s close?
Ans. Ajanta Pharma Share Price closed at Rs 3,597.20 today, compared with the previous close of Rs 3,501.35. That left the stock Rs 95.85 higher on the session and kept it in positive territory.
What is Ajanta Pharma’s market capitalisation?
Ans. Ajanta Pharma’s market capitalisation stood at Rs 43,743.16 crore in the supplied data. That size places the company well above the same-industry median market cap of Rs 741.38 crore. The company operates in the Healthcare sector.
How does Ajanta Pharma compare on valuation?
Ans. Ajanta Pharma trades at a P/E of 38.55 and a P/B of 9.01. Both are above the same-industry medians, which means the stock sits in a richer valuation band than many peers.
Are Ajanta Pharma’s returns on equity and capital strong?
Ans. Yes, the supplied figures show ROE at 25.42% and ROCE at 32.67%. Both are higher than the same-industry median and average, which gives important context to Ajanta Pharma Share Price.
What do EPS, book value and dividend yield show for Ajanta Pharma?
Ans. EPS is Rs 90.82, book value is Rs 388.77 and dividend yield is 0.8%. Together they show earnings per share, accounting net worth per share and the historical payout context.
How does Ajanta Pharma compare with sector peers?
Ans. Ajanta Pharma’s market cap is below Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals, but above Zydus Lifesciences and Cipla. Its returns compare favourably with several supplied peers. The stock belongs to the Healthcare sector.
What sector does Ajanta Pharma belong to?
Ans. Ajanta Pharma belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. Those labels matter because Ajanta Pharma Share Price is being viewed within a specific same-industry benchmark set.
